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a b s t r a c t
The proper removal of superﬂuous neurons through apoptosis and subsequent phagocytosis is essential
for normal development of the central nervous system (CNS). During Drosophila embryogenesis, a large
number of apoptotic neurons are efﬁciently engulfed and degraded by phagocytic glia. Here we
demonstrate that glial proﬁciency to phagocytose relies on expression of phagocytic receptors for
apoptotic cells, SIMU and DRPR. Moreover, we reveal that the phagocytic ability of embryonic glia is
established as part of a developmental program responsible for glial cell fate determination and is not
triggered by apoptosis per se. Explicitly, we provide evidence for a critical role of the major regulators of
glial identity, gcm and repo, in controlling glial phagocytic function through regulation of SIMU and DRPR
speciﬁc expression. Taken together, our study uncovers molecular mechanisms essential for establish-
ment of embryonic glia as primary phagocytes during CNS development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Efﬁcient recognition and elimination of apoptotic cells through
phagocytosis is crucial for normal development of multicellular
organisms. Apoptotic cell clearance is accomplished by two types
of phagocytes: ‘professional’ macrophages and immature dendritic
cells and ‘non-professional’ tissue-resident neighboring cells, whose
role is critical during development (Elliott and Ravichandran, 2008;
Henson and Hume, 2006; Scheib et al., 2012). Phagocytes must
recognize apoptotic particles with high level of speciﬁcity in order to
speciﬁcally remove apoptotic cells but not living normal cells. This
very precise recognition is achieved through transmembrane phago-
cytic receptors or secreted bridging molecules, which recognize ‘eat
me’ signals on apoptotic surfaces (Kinchen and Ravichandran, 2007,
2008a, 2008b; Lauber et al., 2004; Ravichandran, 2011; Ravichandran
and Lorenz, 2007; Stuart and Ezekowitz, 2005).
In mammals, a large number of transmembrane receptors and
soluble bridging molecules have been shown to play a role in
recognition and engulfment of apoptotic particles (Hanayama et al.,
2002; Miyanishi et al., 2007; Park et al., 2007, 2008, 2009).
Importantly, most of these are exclusively expressed in phagocytic
cell populations. However, themolecular mechanisms controlling their
speciﬁc expression remain elusive. Several phagocytic receptors for
apoptotic cells are also known in Drosophila. These receptors show
highly speciﬁc expression in phagocytic cell populations during
embryogenesis. For example, the CD36 homolog Croquemort (CRQ)
is expressed mostly in professional phagocytes, the macrophages
(Franc et al., 1999). Two other receptors, Draper (DRPR) and Six
Microns Under (SIMU), are expressed both in macrophages and in
glia, the non-professional phagocytes of the central nervous system
(CNS) (Freeman et al., 2003; Kurant et al., 2008).
During late embryogenesis a large number of neurons die through
apoptosis and embryonic glia function as the main phagocytes in the
CNS, which efﬁciently remove them (Freeman et al., 2003; Kurant
et al., 2008). Although different functions of glia have recently
received great attention (Allen and Barres, 2005; Barker and Ullian,
2010; Barres, 2008; Chotard and Salecker, 2004; Edenfeld et al., 2005;
Farina et al., 2007; Freeman, 2006; Freeman and Doherty, 2006;
Halassa and Haydon, 2010; Kurant, 2011; Logan and Freeman, 2007;
Pfrieger, 2010; Vilhardt, 2005), mechanisms responsible for preparing
glia to be potent phagocytic cells remain poorly understood.
We have previously shown that SIMU, which is required for
recognition and engulfment of apoptotic neurons by glial cells, is
expressed exclusively during stages of developmental apoptosis in
Drosophila: mid-to-late embryogenesis, pupae and early adult
(Kurant et al., 2008). How this speciﬁc expression, which entirely
correlates with developmentally programmed cell death, is regulated
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remains unclear. In the work presented here, we demonstrate that
the apoptotic process itself does not affect expression levels of
phagocytic receptors SIMU and DRPR in glia but this speciﬁc
expression is part of a developmental program responsible for glial
cell determination. Speciﬁcally, we show that a master regulator of
glial cell fate, glial cells missing (gcm), which is expressed in
precursors of macrophages and early developing glia (Bernardoni
et al., 1997; Hosoya et al., 1995; Jones et al., 1995), induces the
expression of SIMU and DRPR in glia, but not in macrophages. We
also demonstrate that a key regulator of lateral glia development,
reversed polarity (repo) (Halter et al., 1995; Xiong et al., 1994), is
required for DRPR but not SIMU expression in glia. Moreover, we
provide evidence that GCM directly regulates simu expression in glia
through its speciﬁc binding sites, although drpr glial expression
requires repo. Altogether, our study uncovers molecular mechanisms
responsible for establishment of glial phagocytic ability during
development.
Results
Developmental apoptosis during embryogenesis does not affect
expression of the phagocytic receptors SIMU and DRPR
The strong correlation between SIMU expression and develop-
mental apoptosis (Kurant et al., 2008) prompted us to test whether
apoptosis itself promotes expression of phagocytic receptors dur-
ing embryonic development. In order to address this question, we
ﬁrst examined the level of SIMU and DRPR receptors in embryos
lacking developmental apoptosis. A speciﬁc deletion of a genomic
region containing three pro-apoptotic genes reaper, grim and hid
(H99) completely abrogates caspase activation in the embryo,
resulting in lack of developmental apoptosis (White et al., 1994).
We monitored caspase activation in the embryonic CNS by staining
with an anti-cleaved caspase 3 antibody (CM1), which speciﬁcally
labels apoptotic particles in wild type embryo (Fig. 1A) and shows
no reactivity in H99 embryos (Fig. 1B). In H99 mutant embryos we
tested protein expression using anti-SIMU (Fig. 1C, D, G, and H)
and anti-DRPR (Fig. 1E–H) antibodies and detected SIMU and DRPR
proteins on glial membranes similarly to wild type staining which
has been described previously (Kurant et al., 2008, Fig. 1G and H),
indicating that lack of apoptosis does not affect protein levels of
phagocytic receptors. We also did not notice any change in GFP
expression of the simu-cytGFP reporter, which contains a 2 kb
region upstream of simu translation start site fused to cytoplasmic
GFP, which completely recapitulates SIMU embryonic expression
(Kurant et al., 2008, Fig. 1I and J).
Moreover, we measured the levels of simu and drpr transcripts
by qRT-PCR analysis. We detected similar levels of simu cDNA in
the mutant embryos compared to wild type embryos (Fig. 1K),
suggesting that lack of developmental apoptosis does not affect
simu transcriptional levels. Similarly, comparable levels of drpr
cDNA were detected in H99 and wild type embryos (Fig. 1K),
demonstrating that drpr transcript levels are not affected by lack of
apoptosis as well.
To explore, reciprocally, whether elevated apoptosis stimulates
expression of phagocytic receptors during embryogenesis, we
examined simu and drpr expression in embryos with high levels
of apoptosis. To induce excess apoptosis we used elavGal4::hid
transgenic embryos, which show upregulated neuronal apoptosis.
Apoptotic rates were assessed by staining with the CM1 antibody
(Fig. 2A and B). When we tested protein expression of SIMU
(Fig. 2Aʹ, A″, Bʹ, and B″) and DRPR (Fig. 2E and F) in the
elavGal4::hid embryos we observed an abnormal shape of glial
cells labeled with anti-SIMU (Fig. 2B″) and anti-DRPR (Fig. 2F)
antibodies. This glial shape is a result of increased glial engulfment
of higher amounts of apoptotic particles in the elavGal4::hid
embryos (Fig. 2B) as compared to wild type (Fig. 2A). However,
similar levels of SIMU and DRPR proteins were detected (Fig. 2A″,
B″, E, and F), suggesting that increased apoptosis does not affect
protein levels of phagocytic receptors. Moreover, since elavGal4
is transiently expressed in embryonic glia (Berger et al., 2007), in
order to test whether the transient expression of HID in glia
affected glial cell number, we quantiﬁed REPO-labeled glial cells
in entire elavGal4::hid embryonic CNS (Fig. 2D) and compared it
to wild type controls (Fig. 2C). No signiﬁcant difference in glial
cell number was detected between elavGal4::hid and control
embryos (Fig. 2G), demonstrating no glial death in these
embryos.
In addition, qRT-PCR analysis of elavGal4::hid and control
embryos showed that increased apoptosis did not affect the tran-
scriptional levels of simu and drpr during late embryogenesis
(Fig. 2H). Since the expression levels of simu and drpr are relatively
high in normal embryos, it may be difﬁcult to detect an increase in
their expression at this developmental stage. We, therefore, induced
ectopic apoptosis during larval stages when normally no apoptosis
takes place (Fig. 2I). In wild type larvae simu expression levels are
undetectable at this stage (Kurant et al., 2008, Fig. 2K), whereas drpr
expression is lower, as compared to embryogenesis (Flybase expres-
sion data, Figs. S1 and 2Iʹ).
To bypass HID-induced neuronal apoptosis during embryogen-
esis, which is lethal, we conditionally expressed hid in larval
neurons (elavGal4::hid) using the temperature-sensitive Gal80
repressor (tubGal80ts). At 18 1C tubGal80ts is expressed in all
embryonic tissues and prevents elavGal4 from induction of hid
neuronal expression. At 29 1C Gal80 is inactivated and elavGal4 is
derepressed leading to expression of hid speciﬁcally in larval
neurons. We placed the progeny elavGal4::hid; tubGal80 at 18 1C
until the 2nd instar larvae stage and then shifted them to 29 1C for
24 h. Dissected larval brains of the tubGal80ts; elavGal4::hid third
instar larvae were stained with the CM1 antibody to conﬁrm
induction of apoptosis (Fig. 2J and J″), and with speciﬁc antibodies
for SIMU and DRPR in order to evaluate their protein expression
levels. No detectable expression of SIMU was found in these brains
(Fig. 2L) and no difference in DRPR expression was obtained as
compared to wild type (Fig. 2Iʹ, I″, Jʹ, and J″), suggesting that
elevated apoptosis did not affect SIMU and DRPR expression in
larval brains. Moreover, the progeny elavGal4::hid; tubGal80 and
control elavGal4; tubGal80 were subjected to qRT-PCR analysis
following incubation at 29 1C as described above. We found no
increase in drpr expression compared to wild type (Fig. 2H) and no
detectable simu expression in the elavGal4::hid; tubGal80 larvae.
These results indicate that induced apoptosis does not inﬂuence
simu and drpr expression in larval stages, similarly as during
embryogenesis. Altogether, these data suggest that expression of
phagocytic receptors (in glia and macrophages) is not affected by
levels of apoptosis, raising the possibility that their expression is
part of the developmental program responsible for phagocytic cell
fate determination.
glial cells missing (gcm) differentially affects expression of SIMU and
DRPR in haemocytes and glia
gcm is expressed in precursors of ‘professional’ macrophages,
haemocytes, and early lateral glia (Bernardoni et al., 1997; Hosoya
et al., 1995; Jones et al., 1995), making it a promising candidate for
regulation of phagocytic ability of two phagocytic cell populations,
macrophages and glia. In addition, two GCM putative binding sites
have been identiﬁed (Genomatix software) within a 2 kb region
upstream of simu translation start site, which completely recapi-
tulates SIMU embryonic expression (Kurant et al., 2008, Fig. 3A).
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Fig. 1. SIMU and DRPR are expressed on glial membranes in embryos lacking apoptosis. (A–J) Projections from confocal stacks of the CNS at embryonic stage 16, ventral view. (A, B)
Apoptotic particles are labeled with CM1 (red). Bar, 20 mm. (A) Wild type; (B) H99 mutant embryo, in which no CM1 staining is evident. (C, D, G, H) SIMU is localized on glial
membranes of wild type embryo (C, G) andH99mutant embryo alike (D, H) as detected with anti-SIMU antibody. (E, F, G, H) DRPR is localized on glial membranes of wild type embryo
(E, G) and H99mutant embryo (F, H) as detected with anti-DRPR antibody. (I, J) simu-cytGFP reporter is expressed in wild type embryo (I) and H99mutant embryo (J). (K) qRT-PCR for
simu or drpr on wild type and H99 embryos; bars represent mean7SEM. No signiﬁcant changes (n.s., p40.05) in levels of simu or drpr expression are detected based on Student's
t-test statistical analysis.
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gcm and its homolog, gcm2, which is expressed in a very similar
pattern to gcm but at lower levels, share regulatory sequences and
have partially redundant function (Alfonso and Jones, 2002;
Kammerer and Giangrande, 2001). Deletion of both gcm and
gcm2 (Df(2L)Exel7042) results in the elimination of all lateral glial
cells (Alfonso and Jones, 2002), and in about 60% reduction in the
number of macrophages (Bernardoni et al., 1997). To test the role
of gcm in regulation of simu and drpr expression, we examined
embryos lacking the gcm function. In the mutant Df(2L)Exel7042
embryos we did not detect SIMU and DRPR protein expression in
presumptive glia using speciﬁc antibodies against SIMU (Fig. 3D
and D″) and DRPR (Fig. 3F and F″). However, we observed that
SIMU and DRPR were still expressed in macrophages labeled with
the anti CRQ antibody (Fig. 3Bʹ, B″, Cʹ, C″, Dʹ, D″, Eʹ, E″, Fʹ, and F″).
These results indicate that expression of SIMU and DRPR in
macrophages does not depend on gcm, suggesting that gcm affects
SIMU and DRPR expression speciﬁcally in glia. In addition, we
found a very high amount of apoptotic particles in the gcm mutant
(Fig. 3Hʹ and H″) compared to wild type (Fig. 3Gʹ and G″),
indicating an increase in cell death and/or reduction in clearance
of apoptotic cells.
reversed polarity (repo) is required for glial expression of DRPR but not
SIMU
In gcm mutant embryos, the undifferentiated glial cells change
their fate and turn into neurons (Hosoya et al., 1995; Jones et al., 1995;
Mao et al., 2012), leading us to evaluate simu and drpr expression and
glial phagocytic ability in mutants for genes acting downstream to gcm
speciﬁcally in glial cell determination. repo is a master regulator of
lateral glia, which is expressed exclusively in lateral glia during all
stages of ﬂy development (Halter et al., 1995; Xiong et al., 1994). To
investigate whether repo is involved in regulation of SIMU and DRPR
expression, the pattern of these proteins was examined in repomutant
embryos (repo03702). To speciﬁcally label glial cells we used repoGal4::
cytGFP transgenic embryos, where all lateral glial cells express
Fig. 2. SIMU and DRPR expression is unaffected in embryos and larvae with elevated apoptosis. (A–F) Projections from confocal stacks of the CNS at embryonic stage 16,
ventral view. Apoptotic particles are labeled with CM1 (red). Bar, 20 mm. (A–A″, C, E) wild type; (B–B″, D, F) elavGal4::hid embryo. (Aʹ, A″, Bʹ, B″) SIMU staining with anti-SIMU
in green. (C, D) staining of glial nuclei with anti-REPO in blue. (E, F) DRPR staining with anti-DRPR in green. (G) Quantiﬁcation of glial cell number in wild type and elavGal4::
hid CNS. Columns represent mean total number of REPO-positive nuclei within confocal stacks of the entire CNS7SEM, n¼7. n.s. (not signiﬁcant) p40.05, as determined by
one-way ANOVA. (H) qRT-PCR for simu or drpr on wild type and elavGal4::hid embryos and qRT-PCR for drpr on wild type and elavGal4::hid 3rd instar larvae; bars represent
mean7SEM. No signiﬁcant changes (n.s., p40.05) in levels of simu and drpr expression are detected based on Student's t-test analysis. Levels of simu expression in
tubGal80ts; elavGal4::hid 3rd instar larvae were under detection limits of the method. (I–L) Projections from confocal stacks of the 3rd instar larval brains. Apoptotic particles
are labeled with CM1 (red). Bar, 100 mm. (I–I″, K) wild type; (J–J″, L) tubGal80ts; elavGal4::hid brain shows increased CM1 staining. (Iʹ, I″, Jʹ, J″) anti-DRPR in green. (K, L) anti-
SIMU in green.
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cytoplasmic GFP and their shape and behavior are well visualized. In
wild type CNS, GFP-positive glia are stereotypically organized and
express SIMU and DRPR in high levels on their membranes (Fig. 4A, A″,
C, C″, E, and E″). However, in repo mutant embryos, the GFP-positive
glial cells appear different and their organization is impaired (Fig. 4B,
B″, D, D″, F, and F″). Whenwe examined expression of SIMU and DRPR
in repo mutants we found that SIMU was expressed on certain glial
membranes (4576.2% of mutant glia express SIMU, n¼7, Fig. 4Dʹ and
D″) whereas DRPR was absent in all glial cells (Fig. 4Fʹ and F″).
Importantly, in the wild type glia, SIMU is not expressed in all lateral
glia but only in a subset of glial cells (6371.5%, n¼7, Fig. 4Cʹ and C″),
whose number seems to be reduced in the repomutant (see below). In
contrast, SIMU and DRPR are normally expressed in macrophages
(Fig. 4Dʹ, D″, Fʹ, and F″).
repo is required for the phagocytic function of glia
Given that in repo mutant embryos glial cells appear abnormal
and do not express DRPR on their membranes, we tested glial
phagocytosis of apoptotic cells in these embryos. In order to
evaluate if there are more apoptotic particles in the CNS, which
would result from an impaired phagocytosis, we measured the
volume of apoptotic particles labeled with the CM1 antibody. We
observed a much higher volume of CM1-positive apoptotic particles
in the repo mutant CNS compared to wild type (Fig. 5Aʹ, Bʹ, and D).
Moreover, we found that 3376.6% of the apoptotic particles in repo
mutants are not engulfed by phagocytes (n¼7), glia or macro-
phages, compared to 8% in wild type (Kurant et al., 2008). In
addition to impaired phagocytosis, the increase in the volume of
apoptotic particles may result from elevated cell death. We took
two approaches to distinguish between these two possibilities. The
ﬁrst approach was to test whether mutant glia die by apoptosis. We
measured the volume of GFP-positive glial cells labeled by repo-
Gal4::cytGFP in mutant embryos (Fig. 5B and B‴) and compared it to
the wild type embryos (Fig. 5A and A‴). We found that the volume
of glial cells in mutant embryos is half the normal glial volume
(Fig. 5C), suggesting that the amount of glial cells may be reduced.
To quantify the number of glial cells, we marked glial nuclei with
repoGal4::nucGFP (Fig. 5G, G″, H, and H″) and counted the total
number of GFPþnuclei. The same number of GFP-positive nuclei in
repo mutants and wild type embryos were detected (Fig. 5H‴),
indicating that the same number of glial cells are formed in the repo
mutant as in the wild type. Furthermore, we performed TUNEL
analysis to test whether a portion of these nuclei were apoptotic
(Fig. 5H and H″). We found minimal colocalization of nuclear GFP
and TUNEL labeling in repomutants (4.370.6 nuclei), which is non-
signiﬁcant from wild type (370.4, P40.05 as determined by one-
way ANOVA), suggesting that most glia do not die. Therefore, we
propose that the 50 percent reduction in glial volume is a
consequence of abnormal differentiation of certain glial cells
resulting in their smaller volume (Fig. 5B) and leading to the
decreased overall volume of glial cells.
Fig. 3. GCM differentially affects SIMU and DRPR expression in embryonic glia and hemocytes. (A) Schematic illustration of simu promoter region with two putative GCM-
binding sites depicted. (B–H″) Projections from confocal stacks of the CNS at embryonic stage 16, ventral view. Bar, 20 mm. (B–B″) Wild type embryo. Macrophages are labeled
with anti-CRQ (red) and glia are labeled with repoGal4::cytGFP (green). (C–D″) Wild type and gcm mutant embryos are stained with anti-CRQ (red) and anti-SIMU (green).
Note that SIMU is present in mutant macrophages (arrows). (E–F″) Wild type and gcm mutant embryos are stained with anti-CRQ (red) and anti-DRPR (green). Note that
DRPR is present in mutant macrophages (arrowheads). (G–H″) Wild type and gcm mutant embryos are stained with CM1 (red) and anti-SIMU (green). Note the increased
number and volume of apoptotic particles in the mutant.
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Fig. 4. REPO is required for DRPR expression, but is dispensable for SIMU expression in embryonic glia. Projections from confocal stacks of the CNS at embryonic stage 16, ventral view.
Glia are labeled with repoGal4::cytGFP (green). Bar, 20 mm. (A–A″) Wild type and (B–B″) repomutant embryos are stained with anti-CRQ (red). (C–C″) Wild type and (D–D″) repomutant
embryos are stained with anti-SIMU (red). 6371.5% (n¼7) of glial cells express SIMU on their membranes in wild type embryo (Cʹ–C″, arrows) whereas 4576.2% (n¼7) of glial cells
express SIMU on their membranes in the mutant (D–D″, ellipses); this is a signiﬁcant differencewith p valueo0.001, as determined by one-way ANOVA. SIMU is normally expressed in
macrophages (D″, arrowheads). (E–E″) Wild type and (F–F″) repo mutant embryos are stained with anti-DRPR (red). Many glial cells express DRPR on their membranes in wild type
embryo (E″, arrows) but no glial cells express DRPR in repo mutant embryo (F″). DRPR is normally expressed in macrophages of the mutant (F″, arrowheads).
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Fig. 5. REPO is required for differentiation of embryonic glia and their phagocytic function. (A–B‴, G–G″, H–H″, I–J″, K–L″) Projections from confocal stacks of the CNS at
embryonic stage 16, ventral view. Bar, 20 mm. (A–B‴) Glia are labeled with repoGal4::cytGFP (green). (A–A‴) Wild type and (B–B‴) repomutant embryos are stained with CM1
(red) and anti-SIMU (blue). (C) Quantiﬁcation of glial volume. Columns represent mean total volume of GFP-positive cells within confocal stacks of the CNS, 7SEM, n¼7.
(D) Quantiﬁcation of phagocytosis phenotype. Columns represent mean total volume of apoptotic particles within confocal stacks of the CNS, 7SEM, n¼7. (E) Index of
apoptotic particles per glia (volume/volume). Columns represent ratio7SEM, n¼7. (F) Index of apoptotic particles per macrophages (volume/number). Columns represent
ratio7SEM, n¼7. (G–H″) Glial nuclei are labeled with repoGal4::nucGFP (green) and TUNEL is in red. (G–G″) Wild type and (H–H″) repo mutant embryos. (G‴) Columns
represent mean total volume of TUNEL-positive particles within confocal stacks of the CNS, 7SEM, n¼7. (H‴) Quantiﬁcation of glial number. Columns represent mean of
GFP-positive nuclei within confocal stacks of the CNS, 7SEM, n¼7. (I–J″) Live imaging of repoGal4::cytGFP labeled glia following LT injections. (I–I″) Wild type and (J–J″) repo
mutant. Arrows indicate large masses of LT in GFP-negative macrophages. (J‴) Ratio of LT positive area and glial volume. Columns represent mean ratio within confocal stacks
of the CNS, 7SEM, n¼7–10. (C–F, G‴, H‴, J‴) Asterisks indicate statistical signiﬁcance versus wild type, as determined by one-way ANOVA, ***po0.001, **po0.01, n.s. (not
signiﬁcant) p40.05. (K–L″) Glia and macrophages are labeled by simu-cytGFP marker and phagosomes and lysosomes are marked by LT. (Lʹ, L″) Note phagosomes in
macrophages (arrows) and in mutant glia (arrowheads).
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Our second approach was to evaluate phagocytosis by glial
cells. To do this we used LysoTracker (LT) to label phagosomes
(Fig. 5Iʹ, I″, Jʹ, and J″) and calculated the ratio between the volume
of LT-positive area and the GFP-positive glia. This ratio was
signiﬁcantly lower in the CNS of repo mutants as compared to
wild type (Fig. 5J″), demonstrating an impaired phagocytic ability
of repo mutant glia. In addition, we calculated the ratio between
the volume of engulfed CM1 particles and GFP-positive glia. This
ratio was signiﬁcantly higher in the repo mutant than in wild type
(Fig. 5E), indicating that apoptotic particles are overloaded inside
the phagocytic glia, which resembles the drpr mutant phenotype
(Kurant et al., 2008). Altogether, our data show that the increase in
apoptotic cell volume in repo mutants likely results from impaired
glial phagocytosis.
We also detected large masses of LT in cells which were not
labeled with repoGal4::cytGFP (Fig. 5Jʹ and J″), presumably macro-
phages. Indeed, when we used the simu-cytGFP marker, which
speciﬁcally labels macrophages and glia during late embryogenesis
(Kurant et al., 2008), we noticed that the large masses of LT were
located inside the macrophages (Fig. 5Lʹ and L″), indicating their
higher phagocytic activity in repo mutants than in wild type,
probably by doing the ‘glial’ job in clearance of apoptotic cells in
the CNS. To evaluate phagocytosis by macrophages, we counted
the index of apoptotic particles per macrophage and found that it
was signiﬁcantly higher in repomutants than in wild type (Fig. 5F),
suggesting that macrophages perform more phagocytosis in the
mutant. In the wild type condition, at late embryonic stages,
macrophages are unable to enter the CNS because of a physical
barrier formed by surface glia (Kurant et al., 2008, Fig. S4A–C″).
Interestingly, in repo mutants macrophages are found inside the
CNS (Fig. S4D–F″).
repo mutant glia behave in a ‘macrophage-like’ fashion
To monitor the in vivo dynamics of apoptotic cell clearance by
(GFP-positive) glial cells, we used an early marker for apoptotic
cells, Annexin V, which labels speciﬁcally Phosphatidylserine (PS)
on apoptotic cell surfaces (van den Eijnde et al., 1998; Shklyar
et al., 2013b). In the wild type embryonic CNS most of apoptotic
particles are engulfed by glia and co-localize with Annexin V
inside the phagocytes (Fig. 6A–A″ and C). In addition, phagocytic
glia are barely motile and constantly send their protrusions to
engulf apoptotic particles (Kurant et al., 2008; Shklyar et al., 2013a,
movie S2, Fig. 6A–A″ and C). However, repo mutant glia are
abnormally located inside the CNS and lack appropriate contacts
with each other (Fig. 6B, B″, D, and E). Remarkably, some of the
mutant glial cells exhibit increased motility resulting in ‘macro-
phage-like’ movement and are able to engulf multiple apoptotic
particles (Movie S3, Fig. 6D, E, and F–F‴), two ‘macrophage-like’
behaviors. Importantly, this unusual performance of speciﬁc glial
cells correlates with expression of SIMU on their surfaces. We
found that all glial cells that contain multiple apoptotic particles
express SIMU (Fig. 6F–F‴), suggesting that SIMU is a prerequisite
for upregulated engulfment.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.07.005.
SIMU and DRPR expression rescues repo phagocytosis phenotype
To investigate whether impaired glial phagocytic ability in the
repomutant is a result of decreased expression of the receptors SIMU
and DRPR (less or no glial expression, respectively), we performed
rescue experiments. We expressed SIMU or DRPR or both proteins
speciﬁcally in repomutant glial cells using the repoGal4 driver, which
results in strong expression of both receptors on glial membranes
(Fig. 7D, D″, E, E″, F and F″). In all cases, the morphology and
localization of glia appeared abnormal, similarly to the repo mutant
glia (Fig. 7B and B″). Nevertheless, when simu was expressed in
additional glial cells, they were overloaded with apoptotic particles
(Fig. 7D″). This phenotype strongly resembles the drpr single mutant
phenotype, where excess apoptotic particles accumulate inside glia
and macrophages due to the abnormal degradation of the particles
inside the phagocytes (Kurant et al., 2008). Since in our analysis of
phagocytosis phenotype wemeasure the volume of all apoptotic cells
in the CNS (inside and outside glia), the volume of apoptotic cells is
barely affected in the simu rescue embryos and stays close to the
volume in the repo mutant (Fig. 7G). However, we detected a
signiﬁcantly higher percentage of apoptotic particles inside phago-
cytes in repo mutant expressing simu in additional glial cells
(repoGal4::simu, repo03702) than in repo mutant alone (Fig. 7H). These
results suggest that simu expression in glia rescues engulfment
defects. When we similarly expressed drpr in additional glial cells,
we did not rescue the mutant phenotype (Fig. 7G). Since drpr is
mostly involved in degradation (Kurant et al., 2008), its expression in
the mutant glia cannot overcome defects in engulfment, resulting in
excessive apoptotic particles outside glial cells (Fig. 7E″); thus, rescue
of phagocytosis is not observed. Strikingly, when we expressed both
the SIMU and DRPR receptors speciﬁcally in glia, we fully rescued the
mutant phenotype (Fig. 7F–G), indicating that simu is sufﬁcient for
engulfment of apoptotic cells by glial cells and drpr is sufﬁcient for
their degradation. Altogether, our data show that impaired phago-
cytosis in the repo mutant background is a consequence of abnormal
expression of SIMU and DRPR phagocytic receptors.
GCM is sufﬁcient to induce SIMU ectopic expression
Given that GCM and REPO are required for phagocytic function
of glia, particularly by regulating expression of phagocytic recep-
tors SIMU and DRPR, we tested whether these factors are also
sufﬁcient for the receptor expression. We tested this question in
third instar larvae, a stage in which developmental apoptosis does
not occur. Normally, GCM and SIMU are not expressed at this stage
(Kurant et al., 2008, Figs. 8Aʹ and S1), while DRPR is expressed at
relatively low levels (Figs. 8Cʹ and S1). We ectopically expressed
gcm in larval glia using repoGal4 driver, which is active during
larval stages, and examined SIMU and DRPR expression by
immunohistochemistry. Ectopic expression of GCM led to high
levels of SIMU expression in larval CNS glia (Fig. 8Bʹ, B‴, and b),
as compared to wild type controls in which SIMU was
undetectable (Fig. 8Aʹ, A‴, and a). Importantly, larval brains
ectopically expressing GCM exhibited abnormal shape with much
longer ventral nerve cord (VNC) (Fig. 8B‴ and b) compared to wild
type brains (Fig. 8A‴ and a). In contrast, DRPR levels were
unaltered in repoGal4::gcm larval brains (Fig.8Cʹ, C‴, c, Dʹ, D‴,
and d). Interestingly, there was no increase in REPO expression in
repoGal4::gcm larval brains (Fig. 8B″ and D″) compared to control
(Fig. 8A″ and C″) supporting our data obtained in repo mutant
embryos, where REPO is required for DRPR expression. Thus, GCM
is both necessary and sufﬁcient to drive SIMU expression but it is
insufﬁcient for upregulating DRPR expression during third instar
larvae.
GCM regulates simu expression directly through its binding sites in
the simu promoter
As mentioned above, the 2 kb promoter region of simu, which
recapitulates simu expression during embryogenesis, contains two
GCM putative binding sites (Fig. 3A). To test whether GCM
regulates simu expression in glia directly through these sites, we
generated transgenic ﬂies containing the simu-cytGFP reporter
construct lacking the GCM sites (2 kbΔgcm-cytGFP). Two putative
GCM binding sites (Figs. 3A and 9C) were speciﬁcally removed
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from 2 kb simu promoter region using overlapping PCR. The same
landing site (86Fb) was used for generation of transgenic ﬂies
containing the 2 kb control and the modiﬁed 2 kbΔgcm-cytGFP
construct. We stained the 2 kbΔgcm-cytGFP transgenic embryos
with the anti-SIMU antibody to follow SIMU protein expression
(Fig. 9Aʹ and Bʹ) and the anti-CRQ antibody to label macrophages
Fig. 6. Dynamic analysis of glial phagocytosis of apoptotic particles in the embryonic CNS. (A–F‴) Embryonic glia are labeled with repoGal4::cytGFP. Bar, 20 mm. (A–E) Time-
lapse recordings of phagocytosis in stage 16 embryos. PS exposure is labeled by the ﬂuorescent Annexin V (red); (A–A″, C) Wild type embryo. (B–B″, D–F‴) repo mutant
embryo. (C–E) Selected frames are shown (movies are available in the Supplemental data). In wild type (A–A″, C) most of PS positive particles are inside the glial cells. Some
are outside the CNS (asterisks). (B–B″, D, E) repo mutant glia exhibit abnormal shape and localization inside the CNS. Some glial cells become more motile and show
macrophage-like movement (D, ellipse). Some glial cells are super capable of engulfment (D, arrows, E, arrowheads). (F–F‴) Staining with CM1 and SIMU shows glial cells
expressing SIMU with many apoptotic particles inside (arrows), arrowheads point to glia, which do not express SIMU. (F) All GFP-positive glia are labeled with asterisks.
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Fig. 7. SIMU and DRPR expression in glia rescues repo mutant phenotype. (A–F″) Projections from confocal stacks of the CNS at embryonic stage 16, ventral view; apoptotic
cells are in red (CM1) and glia in green (repoGal4::cytGFP). Bar, 20 mm. In wild type embryo (A–A″) apoptotic particles are mostly inside GFP-positive glia. In repo mutant
embryo (B–C″) many apoptotic particles are outside GFP-positive glia (B″) or SIMU-labeled glia and macrophages (C″). In rescue experiments (D–F″) SIMU and DRPR
expression is detected in glial cells (repoGal4 driver) and macrophages with anti-SIMU (D, D″, F, F″) and anti-DRPR (E, E″). (F–G) Complete rescue of the repo null phenotype
with SIMU and DRPR glial speciﬁc expression. No rescue is detected with only SIMU (D–D″, G) or only DRPR (E–E″, G) proteins expressed in glial cells. (G) Quantiﬁcation of
phenotypic rescue of repo null mutants by the different transgenes. Columns represent mean total volume of apoptotic particles within confocal stacks of the CNS, 7SEM,
n¼7. (H) Percent of engulfed apoptotic particles in repo mutant and repo mutant expressing simu with repoGal4 driver where substantial rescue of engulfment is detected.
Columns represent mean percent of apoptotic particles inside SIMU-labeled cells within confocal stacks of the CNS, 7SEM, n¼7. (G, H) Asterisks indicate statistical
signiﬁcance versus wild type, as determined by one-way ANOVA, ***po0.001, **po0.01, n.s. (not signiﬁcant) p40.05.
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(Fig. 9A″ and B″). No GFP expression was found in glia whereas in
macrophages GFP appeared normal (Fig. 9B and B‴). These data
demonstrate that the two GCM binding sites in the 2 kb promoter
are responsible for simu expression in embryonic glia and are
dispensable for simu expression in macrophages. This suggests
that GCM directly regulates simu expression in embryonic glia.
Fig. 8. GCM is sufﬁcient to drive SIMU expression in larval glia but it is dispensable for DRPR expression. (A–D‴) Projections from confocal stacks of the 3rd instar larval brain
lobes stained with anti-REPO (blue, A″, A‴, B″, B‴, C″, C‴, D″, D‴), glia are labeled with repoGal4::cytGFP (green, A, A‴, B, B‴), anti-SIMU (Aʹ, A‴, Bʹ, and B‴) and anti-DRPR (Cʹ,
C‴, Dʹ, and D‴). (a–d) Lower magniﬁcation of larval brains (A, B, C, D) showing abnormal shape of repoGal4::gcm brains (b, d) compared to wild type brains (a, c). Bar, 100 mm.
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Moreover, we ectopically expressed gcm in wild type embryos
using the scaGal4 neuroectoderm driver and tested SIMU expres-
sion. We found strong ectopic SIMU expression in scaGal4::gcm
embryos (Fig. 9E and E″) suggesting that GCM is sufﬁcient to drive
SIMU expression in neurons.
Discussion
Efﬁcient clearance of apoptotic neurons is crucial for normal
CNS development. Recently, vertebrate microglia have been shown
to play a critical role in normal brain development through
clearance of unneeded neurons and remodeling synapses
(Cunningham et al., 2013; Nandi et al., 2012; Sierra et al., 2013;
Sierra et al., 2010; Tremblay et al., 2011). However, the molecular
mechanisms responsible for the formation of microglia as potent
phagocytes during development remain elusive. Unlike verte-
brates, the Drosophila nervous system does not contain microglia
and functionally homologous neuroectoderm-derived glia func-
tion as the main phagocytes during CNS development. We and
others have previously shown that Drosophila phagocytic glia
efﬁciently clear apoptotic neurons during embryonic development
and that two transmembrane receptors SIMU and DRPR are
required for this function (Freeman et al., 2003; Kurant et al.,
2008; Logan et al., 2012; MacDonald et al., 2006; Shklyar et al.,
2013a). However, how this glial phagocytic ability is established
during development and whether apoptosis is involved in this
process was unknown. In this study we showed that the phago-
cytic receptors SIMU and DRPR are expressed on membranes of
embryonic phagocytes, ‘professional’ macrophages and ‘non-pro-
fessional’ glia, independently of developmental apoptosis itself.
We found that this speciﬁc expression is differentially regulated in
macrophages and glia and showed that it is part of the glial fate
determination program. Moreover, we found that GCM is required
for both SIMU and DRPR expression whereas REPO is dispensable
for SIMU expression and is essential for DRPR expression in glia.
Fig. 9. GCM regulates SIMU glial expression directly through its binding sites. (A–B‴, D–E″) Projections from confocal stacks of the CNS at embryonic stage 16, ventral view;
Bar, 20 mm. (A–A‴) simu-cytGFP reporter (GFP); (B–B‴) 2 kbΔgcm-cytGFP reporter (GFP). SIMU is in red (Aʹ, A‴, Bʹ, B‴) and macrophages are in blue (CRQ, A″, A‴, B″, B‴).
(C) Schematic representation of simu-cytGFP and 2 kbΔgcm-cytGFP reporters. (D–E″) SIMU is in green and REPO is in red in wild type (D–D″) and scaGal4::gcm (E–E″)
embryos.
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Using Drosophila embryonic CNS as a model, we examined
whether lack of or increase in apoptosis can inﬂuence expression
of phagocytic receptors, which are required for proper removal of
apoptotic cells during development. Surprisingly, we found that
the rate of apoptosis has no effect on expression levels of
phagocytic receptors, suggesting that phagocytes are ready to
recognize and remove apoptotic particles as part of their correct
differentiation. As we have previously shown, engulfment of apop-
totic cells occurs rapidly (Kurant et al., 2008; Shklyar et al., 2013a)
and there is likely not enough time to up-regulate transcription or
translation of phagocytic receptors. Therefore, they have to be
placed on phagocytic membranes ahead of the uptake itself.
However, posttranslational modiﬁcation of DRPR in response to
apoptosis cannot be ruled out. On the other hand, during normal
development in the absence of apoptosis, the expression of SIMU is
below detection, and during apoptotic waves its expression is
extremely high (Fig. S3). Since SIMU does not undergo any post-
translational modiﬁcations (Kurant et al., 2008), it seems to be
tightly regulated transcriptionally in order to be present only when
needed. However, DRPR activity can be modulated by posttransla-
tional modiﬁcations (Ziegenfuss et al., 2008); hence it might be less
dependent on the levels of transcription, which barely change
during development (Fig. S1). Interestingly, recent studies on glial
engulfment of injured axons in adult Drosophila brain showed that
levels of DRPR were elevated as a response to the injury (Macdonald
et al., 2013) suggesting that different molecular pathways regulate
DRPR levels in the developing and adult CNS.
Both SIMU and DRPR are glial phagocytic receptors (Freeman et al.,
2003; Kurant et al., 2008; Logan et al., 2012; MacDonald et al., 2006;
Shklyar et al., 2013a) though their expression pattern is different. DRPR
is expressed during all stages of ﬂy development and has been shown
to play a role in many different processes mediated by glia. In most of
these processes it is required for the degradation of engulfed material
inside phagocytic glia (Kurant et al., 2008; Logan et al., 2012;
MacDonald et al., 2006). However, SIMU is expressed exclusively
during developmental apoptosis and it is required speciﬁcally for the
recognition and engulfment of apoptotic particles (Kurant et al., 2008;
Shklyar et al., 2013a). In search for regulators of SIMU and DRPR
expression, we ﬁrst focused on GCM, whose expression correlates
with that of SIMU and DRPR during embryonic development in
macrophages and glia. Moreover, drprwas found in the genetic screen
for GCM-regulated genes expressed during embryogenesis (Freeman
et al., 2003). Recently, it has been shown that the GCM protein is still
present in glia at late embryonic stages (Laneve et al., 2013) when simu
and drpr are highly expressed. Indeed, we found that GCM is
responsible for SIMU and DRPR expression though only in glia
(Fig. 10) and not in macrophages, suggesting that distinct develop-
mental programs function in different phagocytic cells. Moreover, our
experiments show that ectopic expression of GCM in larval glia
induces SIMU expression (Fig. 8Bʹ, B‴, and b) while DRPR as well as
REPO levels remain unchanged (Fig. 8Dʹ, D‴, and d). Furthermore, we
demonstrated that GCM controls SIMU expression in glia directly,
through its binding sites in the simu promoter (Fig. 9A–C). In addition,
since GCM is expressed in all lateral glia, we propose that gcm-
regulated expression of SIMU is repressed in a subset of lateral glia,
which does not normally express SIMU. It will be intriguing to further
investigate this suggestion and explore the mechanism, which restricts
SIMU expression to the speciﬁc glial cells. The situation is different for
DRPR, where GCM acts through its downstream target REPO, which is
required and sufﬁcient for DRPR embryonic expression (Fig. 10), since
in repo mutant embryos there is no DRPR in glia even in the presence
of GCM (Fig. 4) and ectopic expression of repowith the neuroectoderm
driver scaGal4 leads to ectopic expression of DRPR in neurons (Fig. S5).
repo and drpr are required for diverse glial functions, apart from
apoptotic cell clearance, and are expressed during all stages of
development. However, simu expression does not depend on repo
(Fig. 10) and simu-expressing repomutant glia are capable of engulﬁng
apoptotic particles very efﬁciently. Strikingly, some repo mutant cells
resemble macrophages in their increased motility and uptake capacity
resulting in engulfment of multiple apoptotic cells. We found that
these cells express SIMU on their surfaces. This ‘macrophage-like’
behavior could be a transitional state of developing glia, and only
when glia further differentiate, they make proper cell-cell contacts,
stop moving and become imbedded in their determined place. An
important part of this glial differentiation is to be able not only to
recognize and engulf apoptotic particles, but also to degrade them
intracellularly, which necessitates REPO regulation of DRPR expres-
sion. An intriguing idea would be to test DRPR's role as an inhibitory
receptor, preventing glial membrane extension, analogous to the
role of DRPR's vertebrate homologs MEGF10/MEGF11 in tiling of
retinal neurons (Kay et al., 2012).
Our rescue experiments show that when additional glial cells
express simu, the engulfment defects of repo mutant glia are
substantially rescued, which is reﬂected by much a higher percen-
tage of engulfed apoptotic particles compared to repo mutant
(Fig. 7H). Nonetheless, simu expressing mutant glia are unable to
degrade apoptotic particles, resulting in accumulation of particles
trapped inside the phagocytes (Fig. 7). Moreover, DRPR expression
alone is unable to rescue phagocytosis because DRPR is not
sufﬁcient for engulfment. Normally, not all lateral glia perform
phagocytosis. Here we provide evidence that if SIMU and DRPR
are expressed in additional glial cells, they become completely
functional phagocytes suggesting that intracellular phagocytic
machinery responsible for cytoskeleton rearrangement and pha-
golysosome formation (Ravichandran and Lorenz, 2007) is already
established in these cells.
Taken together, our data show that the ability of embryonic glia
to properly remove and degrade apoptotic cells is built up by
distinct steps during differentiation. Initial steps governing forma-
tion of intracellular phagocytic machinery seem to be common in
macrophages and glia while later steps, which involve SIMU and
DRPR receptors expression, are speciﬁcally determined during glial
cell fate determination. In summary, using the Drosophila embryo-
nic CNS as a model, our study uncovers molecular mechanisms
essential for establishment of embryonic glia as primary phago-
cytes during CNS development. Given the critical role of glial
phagocytosis in development and maintenance of the CNS we
believe that our data may open new directions in understanding
glial cell biology of higher organisms.
Conclusions
Removal of apoptotic cells is crucial for normal development of
multicellular organisms, especially in the developing CNS where
many neurons die through apoptosis. These apoptotic neurons are
efﬁciently cleared by glia, which are primary phagocytes in the CNS.
It is not clear how these highly phagocytic cells are established
during development. Using Drosophila embryonic CNS as a model we
show that glial phagocytic ability relies on expression of phagocytic
receptors SIMU and DRPR, which are key factors involved in distinct
steps of apoptotic cell clearance, engulfment and degradation. We
provide evidence that SIMU and DRPR are sufﬁcient to make each
glial cell phagocytic. However, their embryonic expression is not
affected by apoptosis but strongly depends on master regulators of
glial fate determination, GCM and REPO, which differentially control
SIMU and DRPR. GCM directly regulates simu expression whereas
drpr requires REPO function. These data indicate that the glial
developmental program generates competence in the glial cells to
act as primary phagocytes in the CNS.
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Materials and methods
Fly strains and constructs
The following ﬂy strains were used in this work: repoGal4
(B. Jones), UAScytGFP (♯ 1521; Bloomington), repo03702/TM3 (♯ 11604;
Bloomington), elavGal4 (O. Schuldiner), UAShid (E. Arama), Df (3L) H99
(H. Steller), simu-cytGFP (Kurant et al., 2008), Df(2L)Exel7042 (♯7812;
Bloomington), UASnGFP (♯ 4775; Bloomington), UASrepo and UASdrpr
(M. Freeman), UASgcm (♯5446; Bloomington), UASsimu (Shklyar et al.,
2013a), tubGal80ts (♯7019; Bloomington), scaGal4 (A. Salzberg). We
placed progeny elavGal4::hid; tubGal80 at 18 1C until the 2nd instar
larval stage and then shifted them to 29 1C for 24 h.
Reporter constructs were generated by cloning the 2 kb or
2 kbΔgcm upstream regulatory region of simu into the pattB vector
containing a cytoplasmic GFP coding sequence. These transgenes
were inserted into the attP86 site on chromosome 3R using the
QC31 system (Venken et al., 2006). All strains were raised at 25 1C.
w1118 ﬂies were used as wild type control.
qRT-PCR
RNA was isolated from tissue samples (embryos or larvae)
using RNazolsRT (MRC) and a hand homogenizer. Following
DNase treatment RNA was used as a template for cDNA synthesis
(M-MLV RT and RNasin: Promega). Gene expression was evaluated
using TaqMan gene expression assays (Applied Biosystems) spe-
ciﬁc for simu (nimC4) – Dm01791334_s1, drpr – Dm01832226_g1
or RPII140 – Dm02134593_g1 (as an internal control). The PCR
reactions were set up following the manufacturer's instructions.
The assays were performed in triplicate with RNA samples from at
least three different isolations. Relative gene expression was
quantitated using the comparative method (ΔΔCT). Graphs repre-
sent the fold change of target gene expression in mutant com-
pared to control samples. The Student's t-test was used for
statistical analysis. Po0.05 was considered to indicate a statisti-
cally signiﬁcant difference.
Immunohistochemistry and live imaging
For immunohistochemistry embryos were ﬁxed and stained
according to standard procedures. Guinea pig anti-SIMU (Shklyar
et al., 2013a) and rabbit anti-DRPR (M. Freeman) were used at a
1:5000 and 1:500 concentrations respectively. Rabbit anti-
activated caspase 3 (CM1, BD) and mouse anti-GFP (Roche) were
used at 1:100 concentration. Rabbit anti-CRQ antibody (1:500)
was a gift from N. Franc. Mouse anti-Repo antibody (Hybridoma
bank) was used at 1:5 concentration. Fluorescent secondary
antibodies (Cy3/Jackson ImmunoResearch; Alexa Fluor 488/Mole-
cular Probes) were used at 1:200 dilutions. All confocal images
were acquired on a confocal microscope Zeiss LSM 700 using an EC
Plan-Neoﬂuar 40 /1.30 Oil DIC M27 or a Plan-Apochromat 20 /
0.8 M27 lens. 75% Glycerol solution was used as the imaging
medium. Image analysis was performed using Zeiss LSM 700 and
Imaris (Bitplane) software. To quantitate the volume of apoptotic
particles or glial cells, confocal stacks (5 sections; total 7.5 mm)
were acquired from the neural cortex of stage 16 ventral nerve
cords. For quantiﬁcation of glial cell number in entire CNS (Fig. 2C
and D) 10 sections, total 15 mm were acquired.
Live imaging was carried out by dechorionating embryos (stage
15), mounting them under Halocarbon oil, injecting 2%-3% egg
volume Alexa ﬂuor 555 conjugated Annexin V (Molecular Probes)
or LysoTracker (Molecular Probes) as described in (Shklyar et al.,
2013b). Recording started 30 min following injection.
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